Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V.

Saved in:
Bibliographic Details
Title: Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V.
Authors: Gien, Lilian T.1 (AUTHOR) lilian.gien@sunnybrook.ca, Song, Zihe2 (AUTHOR), Poklepovic, Andrew3 (AUTHOR), Collisson, Eric A.4 (AUTHOR), Zwiebel, James A.5 (AUTHOR), Gray, Robert J.2 (AUTHOR), Wang, Victoria2 (AUTHOR), McShane, Lisa M.6 (AUTHOR), Rubinstein, Larry V.6 (AUTHOR), Patton, David R.7 (AUTHOR), Williams, P. Mickey8,9 (AUTHOR), Hamilton, Stanley R.10 (AUTHOR), Tricoli, James V.11 (AUTHOR), Conley, Barbara A.11 (AUTHOR), Arteaga, Carlos L.12 (AUTHOR), Harris, Lyndsay N.11 (AUTHOR), O'Dwyer, Peter J.13 (AUTHOR), Chen, Alice P.14 (AUTHOR), Flaherty, Keith T.15 (AUTHOR)
Source: JCO Precision Oncology. 12/12/2024, Vol. 8, p1-9. 9p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first